Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Your provider may want you to wait an extra week before resuming, or restart at a lower dose
The FDA granted accelerated approval for this indication in August 2025, and the 2026 American Diabetes Association Standards of Care now recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes and biopsy-proven MASH or high fibrosis risk
$400 for 1 month
Semaglutide (Rybelsus) is an oral GLP-1 agonist approved for type 2 diabetes, dosed at 3 mg, 7 mg, or 14 mg daily
US$ 21.68
US$ 20.78
US$ 25.09
US$ 29.42
US$ 24.42
